Atyr Pharma Inc (ATYR)

$0.75 +0.04 (5.58%)
Market Cap 70.83M
Revenue (ttm) 240,000.00
Net Income (ttm) -64.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -26,675.00%
Debt to Equity Ratio 0.00
Volume 3,485,791
Avg Vol 12,855,212
Day's Range N/A - N/A
Shares Out 97.99M
Stochastic %K 8%
Beta 0.81
Analysts Sell
Price Target $5.20

Company Profile

aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitiv...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 731 8389
Fax: 858 731 8394
Address:
10240 Sorrento Valley Road, Suite 300, San Diego, United States
HedgeAlerts
HedgeAlerts Nov. 14 at 5:43 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ATYR $0.50 Put · NOV 21, 2025 Exp Entry Price: $0.01 - $0.05 Exit Price Target: $0.01 Profit Margin: +46% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
__Godzilla__
__Godzilla__ Nov. 14 at 2:54 PM
$ATYR To All: Ignore HBall123. It is Jokt, who was banned in October, posting his nonsense under a new name. (HBall123 started his account in...October.) Expect a continuous stream of commentary, sometimes several times an hour, on how bad an investment aTyr is. He is shorting aTyr, so he is not an objective source of information. Don't get me wrong. A person can be objectively bearish on aTyr. It could go to zero. I have said that myself. But making false statements (saying that it was delisted) or repeating the same bearish opinion several times an hour to profit yourself is a clown's game. Don't fall for his foolishness.
0 · Reply
HBall123
HBall123 Nov. 14 at 2:32 PM
$ATYR No volume here market dumping gonna be nasty for the 1 hit wonder
0 · Reply
HBall123
HBall123 Nov. 14 at 2:29 PM
$ATYR ATYR about to dive deep today ..breaks resistance look out below …
0 · Reply
heyupikachu1821
heyupikachu1821 Nov. 14 at 2:11 PM
$AVXL something I learned from $ATYR… if you start seeing large volume sell-offs just before expected data, someone knows. leaks, insider trading, whatever the case… go back and look at how many large volume sell-offs occurred (esp after hours). study what happened here, watch out for it in future investments not here to deride or add further pain. just here to say, these are lessons you can log and use in the future (I don’t short and was not short here, but I did pull out an investment for a loss due to increasing warning signs) best of luck to everyone moving forward
2 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:03 AM
Hedge Alert Live - Protect Your Portfolio Contract: $ATYR $0.50 Put · NOV 21, 2025 Exp Entry Price: $0.01 - $0.05 Exit Price Target: $0.02 Profit Margin: +133% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 6:32 AM
💎 LiquidTheta® Live Actionable Trade Asset: $ATYR Contracts: $ATYR January 15, 2027 $1 Calls Scale in: $0.21- $0.26 Scale out: $0.83-$1.42 Profit Potential : 104% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Grass_fire
Grass_fire Nov. 13 at 9:30 PM
$ATYR I think Q1 this will bounce back to $2
0 · Reply
StreetwiseReports
StreetwiseReports Nov. 13 at 9:18 PM
Lead Drug Faces Uncertain FDA Path After Phase 3 Miss https://ow.ly/PKTE50Xro2Q aTyr Pharma Inc. ($ATYR:NASDAQ) is seeking regulatory clarity following mixed Phase 3 results for its lead candidate efzofitimod in pulmonary sarcoidosis. The company expects feedback from the FDA in the first quarter of 2026 to help determine a potential path forward.
0 · Reply
HBall123
HBall123 Nov. 13 at 7:03 PM
$ATYR Trying to hold Support here if she doesn’t look out below…..
1 · Reply
Latest News on ATYR
aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman

Nov 11, 2025, 9:23 AM EST - 3 days ago

aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

Nov 11, 2025, 3:02 AM EST - 3 days ago

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Nov 10, 2025, 5:42 PM EST - 4 days ago

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 10, 2025, 8:00 AM EST - 4 days ago

aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference

aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update

Nov 6, 2025, 4:01 PM EST - 8 days ago

aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ATyr Pharma

Nov 4, 2025, 11:49 AM EST - 10 days ago

ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ATyr Pharma

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Oct 30, 2025, 11:33 AM EDT - 15 days ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit - ATYR

Oct 30, 2025, 8:45 AM EDT - 15 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 8, 2025 in aTyr Lawsuit - ATYR

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Oct 28, 2025, 9:34 AM EDT - 17 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

ATYR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

Oct 23, 2025, 1:28 PM EDT - 22 days ago

ATYR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman

Oct 22, 2025, 4:49 PM EDT - 23 days ago

aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

Oct 9, 2025, 1:50 PM EDT - 5 weeks ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower – Hagens Berman

Oct 3, 2025, 2:32 PM EDT - 6 weeks ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower – Hagens Berman

Ethos Technologies Targets IPO Amid Positive Insurance Offerings

Sep 30, 2025, 2:59 PM EDT - 6 weeks ago

Ethos Technologies Targets IPO Amid Positive Insurance Offerings

LIFE

aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society (ERS) Congress 2025

Sep 30, 2025, 5:30 AM EDT - 6 weeks ago

aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society (ERS) Congress 2025

Ethos Files Registration Statement for Proposed Initial Public Offering

Sep 26, 2025, 1:50 PM EDT - 7 weeks ago

Ethos Files Registration Statement for Proposed Initial Public Offering

LIFE

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT™ Study Failure Drives Shares 80% Lower -- Hagens Berman

Sep 23, 2025, 9:22 AM EDT - 7 weeks ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT™ Study Failure Drives Shares 80% Lower -- Hagens Berman

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

Sep 22, 2025, 11:08 AM EDT - 7 weeks ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman

Top 3 Health Care Stocks That May Explode In September

Sep 19, 2025, 7:01 AM EDT - 2 months ago

Top 3 Health Care Stocks That May Explode In September

BSX RVPH

Foundation for Sarcoidosis Research Reacts to the Announcement of aTyr Pharma's Phase 3 Clinical Trial Results

Sep 17, 2025, 10:01 AM EDT - 2 months ago

Foundation for Sarcoidosis Research Reacts to the Announcement of aTyr Pharma's Phase 3 Clinical Trial Results

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FITÔ Study Failure Drives Shares 80% Lower -- Hagens Berman

Sep 17, 2025, 9:03 AM EDT - 2 months ago

aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FITÔ Study Failure Drives Shares 80% Lower -- Hagens Berman

ATyr Pharma, Inc. (ATYR) Announces Top Line Results For The Phase III EFZO-FIT Study Of Efzofitimod In Pulmonary Sarcoidosis (Transcript)

Sep 15, 2025, 1:16 PM EDT - 2 months ago

ATyr Pharma, Inc. (ATYR) Announces Top Line Results For The Phase III EFZO-FIT Study Of Efzofitimod In Pulmonary Sarcoidosis (Transcript)

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR

Sep 15, 2025, 12:06 PM EDT - 2 months ago

aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ATYR

ATyr Pharma Stock Sinks, Plans FDA Review After Mixed Phase 3 Results

Sep 15, 2025, 11:24 AM EDT - 2 months ago

ATyr Pharma Stock Sinks, Plans FDA Review After Mixed Phase 3 Results

BREAKING: aTyr Pharma Shares Plummet 80%; Investors Should Contact Block & Leviton to Potentially Recover Losses

Sep 15, 2025, 10:57 AM EDT - 2 months ago

BREAKING: aTyr Pharma Shares Plummet 80%; Investors Should Contact Block & Leviton to Potentially Recover Losses

aTyr Pharma's lung disease drug misses main goal in late-stage trial

Sep 15, 2025, 7:55 AM EDT - 2 months ago

aTyr Pharma's lung disease drug misses main goal in late-stage trial

aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis

Sep 15, 2025, 7:30 AM EDT - 2 months ago

aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 5, 2025, 4:00 PM EDT - 2 months ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

aTyr Pharma Announces Second Quarter 2025 Results and Provides Corporate Update

Aug 7, 2025, 4:00 PM EDT - 3 months ago

aTyr Pharma Announces Second Quarter 2025 Results and Provides Corporate Update

Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors

Jul 30, 2025, 11:00 AM EDT - 3 months ago

Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors

LIFE

HedgeAlerts
HedgeAlerts Nov. 14 at 5:43 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ATYR $0.50 Put · NOV 21, 2025 Exp Entry Price: $0.01 - $0.05 Exit Price Target: $0.01 Profit Margin: +46% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
__Godzilla__
__Godzilla__ Nov. 14 at 2:54 PM
$ATYR To All: Ignore HBall123. It is Jokt, who was banned in October, posting his nonsense under a new name. (HBall123 started his account in...October.) Expect a continuous stream of commentary, sometimes several times an hour, on how bad an investment aTyr is. He is shorting aTyr, so he is not an objective source of information. Don't get me wrong. A person can be objectively bearish on aTyr. It could go to zero. I have said that myself. But making false statements (saying that it was delisted) or repeating the same bearish opinion several times an hour to profit yourself is a clown's game. Don't fall for his foolishness.
0 · Reply
HBall123
HBall123 Nov. 14 at 2:32 PM
$ATYR No volume here market dumping gonna be nasty for the 1 hit wonder
0 · Reply
HBall123
HBall123 Nov. 14 at 2:29 PM
$ATYR ATYR about to dive deep today ..breaks resistance look out below …
0 · Reply
heyupikachu1821
heyupikachu1821 Nov. 14 at 2:11 PM
$AVXL something I learned from $ATYR… if you start seeing large volume sell-offs just before expected data, someone knows. leaks, insider trading, whatever the case… go back and look at how many large volume sell-offs occurred (esp after hours). study what happened here, watch out for it in future investments not here to deride or add further pain. just here to say, these are lessons you can log and use in the future (I don’t short and was not short here, but I did pull out an investment for a loss due to increasing warning signs) best of luck to everyone moving forward
2 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 7:03 AM
Hedge Alert Live - Protect Your Portfolio Contract: $ATYR $0.50 Put · NOV 21, 2025 Exp Entry Price: $0.01 - $0.05 Exit Price Target: $0.02 Profit Margin: +133% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 6:32 AM
💎 LiquidTheta® Live Actionable Trade Asset: $ATYR Contracts: $ATYR January 15, 2027 $1 Calls Scale in: $0.21- $0.26 Scale out: $0.83-$1.42 Profit Potential : 104% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
Grass_fire
Grass_fire Nov. 13 at 9:30 PM
$ATYR I think Q1 this will bounce back to $2
0 · Reply
StreetwiseReports
StreetwiseReports Nov. 13 at 9:18 PM
Lead Drug Faces Uncertain FDA Path After Phase 3 Miss https://ow.ly/PKTE50Xro2Q aTyr Pharma Inc. ($ATYR:NASDAQ) is seeking regulatory clarity following mixed Phase 3 results for its lead candidate efzofitimod in pulmonary sarcoidosis. The company expects feedback from the FDA in the first quarter of 2026 to help determine a potential path forward.
0 · Reply
HBall123
HBall123 Nov. 13 at 7:03 PM
$ATYR Trying to hold Support here if she doesn’t look out below…..
1 · Reply
cninc
cninc Nov. 13 at 6:57 PM
$ATYR
0 · Reply
OnlyBuyMoreShareSqueezes
OnlyBuyMoreShareSqueezes Nov. 13 at 6:47 PM
$ATYR lets keep it going
0 · Reply
sloshy665
sloshy665 Nov. 13 at 6:43 PM
$AVXL sorry guys im on the wrong board 😅😅😅😅🤣🤣🤣🤣 i meant $ATYR
1 · Reply
FinABAT
FinABAT Nov. 13 at 4:52 PM
$AVXL shutup lol. He was spot on about $ATYR and $SAVA This is headed to 1
0 · Reply
Struin
Struin Nov. 13 at 4:41 PM
$ATYR Total market is a drama, all red!!! So patience.
0 · Reply
Zaens
Zaens Nov. 13 at 4:13 PM
$ATYR going to zero
0 · Reply
MATTHEWvANBICHEN
MATTHEWvANBICHEN Nov. 13 at 9:59 AM
$ATYR Many intitutions invested here like vanguard etc. Good pipeline from first 2026. Good cash position no dilution on near term..
1 · Reply
Anakin06
Anakin06 Nov. 13 at 9:41 AM
$ATYR I have no clue why are you still buying this one ? You really think there is a chance to going back to 1 ?
4 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 12 at 11:51 PM
💎 LiquidTheta® Live Actionable Trade Asset: $ATYR Contracts: $ATYR January 15, 2027 $1 Calls Scale in: $0.25- $0.30 Scale out: $0.96-$1.65 Profit Potential : 362% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
MATTHEWvANBICHEN
MATTHEWvANBICHEN Nov. 12 at 9:27 PM
$ATYR added more, nice discount
3 · Reply
OnlyBuyMoreShareSqueezes
OnlyBuyMoreShareSqueezes Nov. 12 at 2:30 PM
$ATYR $WLFI.X $MEW.X $ATER To all my fellow buyers and holders, these are my favorites stocks and crypto to accumulate , not telling you to get in or get out, but if you want to research them, i would say these are very great long term. I have a decently big position for myself, I am looking for big gains, don't mind any volatility, but when the green candles come they are great. I am not selling any of them , I distribute my paycheck into each individually and hold
1 · Reply
LetsCHere
LetsCHere Nov. 12 at 1:21 PM
$AVXL This clown was asked yesterday to post a photo of his new short position and he failed to do so and blocked in return! lmao BanditQ Follow $AVXL opened a short position today. I like free money. This is going to cash value at $1.22 u have been warned just like $ATYR losers Nov 11, 2025 4:36 PM
2 · Reply